Skip to main content
The Egyptian Journal of Bronchology
Download PDF

Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion

Egyptian Journal of Bronchology volume 10, pages 100–104 (2016)Cite this article

Abstract

Introduction

Malignant pleural effusion (MPE) is a common problem and a real challenge to pulmonologists and oncologists. The optimum management of MPE depends on several factors, including patient’s symptoms and primary tumor status. Complete drainage and pleurodesis to prevent recurrence is usually needed. Tetracycline, talc, and bleomycin are considered the primary sclerosing agents.

Aim of the study

The aim of the study was to investigate the feasibility, effectiveness, and safety of thoracoscopically insufflated tetracycline powder to achieve pleurodesis in patients with MPE.

Patients and methods

Twenty patients with recurrent pleural effusion that proved to be malignant, or showing a picture highly suggestive of pleural malignancy at thoracoscopy, were included in the study. They were subjected to tetracycline poudrage (35 mg/kg) through medical thoracoscopy. Following discharge, patients were followed up at 3 and 6 months; the primary outcome was the measure of pleurodesis failure, defined as the reaccumulation of pleural fluid requiring further pleural intervention.

Results

Of the 20 patients included in this study, five were excluded from evaluation (two because of failure of lung re-expansion and three because of death within 2 months of the procedure). The overall success rate of thoracoscopic tetracycline poudrage pleurodesis in the 15 patients with MPE who completed the study was 86.6%. There was no recorded mortality or significant complications.

Conclusion

From this pilot study, we can conclude that thoracoscopy with tetracycline poudrage is an easy, safe, and effective method for performing pleurodesis in MPE.

References

  1. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline. Thorax 2010;65:ii32–ii40.

  2. Walker SJ, Bryden G. Malignant pleural effusions. Clin J Oncol Nurs 2010;14:59–64.

    Article  Google Scholar 

  3. Judson M,Sahn S. Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Crit Care Med 1995;16:346e53.

  4. Zalcman G, Lechapt E, Bergot E. Management of malignant pleural effusion. Rev Prat 2007;57:513–523.

    PubMed  Google Scholar 

  5. Muduly DK, Deo SVS, Subi TS, Kallianpur AA, Shukla NK. An update in the management of malignant pleural effusion. Indian J Palliat Care 2011;17:98–103.

    Article  Google Scholar 

  6. Astoul P. Pleurodesis for recurrent malignant pleural effusions: the quest for the holy grail. Eur J Cardiothorac Surg 2011;40:277–279.

    PubMed  Google Scholar 

  7. Rodriguez-Panadero F, Romero-Romero B. Management of malignant pleural effusions. Curr Opin Pulm Med 2011;17:269–273.

    Article  Google Scholar 

  8. Rodriguez-Panadero F, Janssen JP, Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 2006;28:409–421.

    Article  CAS  Google Scholar 

  9. American Thoracic Society. Management of malignant pleural effusion. Am J Respir Crit Care Med 2000;162:1987–2001.

    Article  Google Scholar 

  10. Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58:1129–1138.

    Article  Google Scholar 

  11. Villanueva AG, Gray AW Jr, Shahian DM, Williamson WA, Beamis JF Jr. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994;49:23–25.

    Article  CAS  Google Scholar 

  12. Sherman S, Grady KJ, Seidman JC. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J 1987;80:716–719.

    Article  CAS  Google Scholar 

  13. Bayly TC, Kisner DL, Sybert A, Macdonald JS, Tsou E, Schein PS. Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial. Cancer 1978;41:1188–1192.

    Article  CAS  Google Scholar 

  14. Martinez-Moragon E, Aparicio J, Rogado MC, Sanchis J, Sanchis F, Gil-Suay V. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 1997;10:2380–2383.

    Article  CAS  Google Scholar 

  15. Tetty M, Sereboe L, Edwin F, Frimpong-Boateng K. Tetracycline pleurodesis for malignant pleural effusion - a review of 38 cases. Ghana Med J 2005;39:128–131.

    Google Scholar 

  16. Evans TR, Stein RC, Pepper JR, Gazet JC, Ford HT, Coombes RC. A randomized prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer 1993;29A:316–319.

    Article  CAS  Google Scholar 

  17. Fentiman IS, Rubens RD, Hayward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 1986;22:1079–1081.

    Article  CAS  Google Scholar 

  18. Landvater L, Hix WR, Mills M, Siegel RS, Aaron BL. Malignant pleural effusion treated by tetracycline sclerotherapy. A comparison of single vs. repeated instillation. Chest 1988;93:1196–1198.

    Article  CAS  Google Scholar 

  19. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120:56–64.

    Article  CAS  Google Scholar 

  20. Boutin C, Rey F, Viallat JR. Randomized study of the efficacy of thoracoscopic talc poudrage and the instillation of tetracycline in the management of recurrent malignant pleural effusion. Rev Fr Mal Respir 1985;2:374.

    Google Scholar 

  21. Wooten SA, Strange C, Barbarash R, Sahn SA. Pharmacokinetics of tetracycline and lidocaine following intrapleural instillation. Am Rev Respir Dis 1987;135:A245.

    Google Scholar 

  22. Hartman DI, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993;106:743–748.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Diseases, Faculty of Medicine, Ain Shams University, 43 El-Mahrouky Street, Cairo, Heliopolis, 11341, Egypt

    Magdy Khalil & Amr M. Shoukri (MD)

Authors
  1. Magdy Khalil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amr M. Shoukri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amr M. Shoukri.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khalil, M., Shoukri, A.M. Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion. Egypt J Bronchol 10, 100–104 (2016). https://doi.org/10.4103/1687-8426.184358

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.184358

Keywords